GlassScriptPhysician profile
Matthew S Ivey
NPI 1316069990
$6,741.87
in general payments reported to CMS, 2019-2025
14 companies · $573 in 2025
The $573 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,355 · 2020: $297 · 2021: $1,728 · 2022: $976 · 2023: $611 · 2024: $1,201 · 2025: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,385.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,201.31 | 2019-2025 | Augment Injectable, Ortholoc 3di, Citrefix |
| Wright Medical Technology, INC. | $1,351.18 | 2019-2020 | |
| Medinc of Texas | $1,251.36 | 2021-2025 | |
| Treace Medical Concepts, INC. | $317.15 | 2024-2025 | |
| Smith+Nephew, INC. | $210.68 | 2024-2025 | Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl |
| Nevro Corp. | $123.55 | 2024 | Senza |
| Arthrex, INC. | $88.45 | 2022 | |
| Amgen INC. | $45.46 | 2024-2025 | Krystexxa |
| Paragon 28, INC. | $45.02 | 2024 | Gorilla |
| Integra Lifesciences Corporation | $38.73 | 2025 | Neuragen, Cytal |
| Paratek Pharmaceuticals, INC. | $20.50 | 2025 | Nuzyra |
| Bioventus LLC | $19.97 | 2025 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $16.62 | 2025 | Affinity |
| Kerecis Limited | $11.89 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ivey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.